Fremanezumab Treatment of Migraine in Women With Menstrual Migraine Ages 18-45

Conditions: Migraine; Menstrual Migraine; Menstrually Related Migraine Interventions: Drug: Fremanezumab; Other: Placebo Sponsors: Brigham and Women ' s Hospital; Teva Pharmaceuticals USA Not yet recruiting

https://clinicaltrials.gov/study/NCT06173661

Source: ClinicalTrials.gov - December 18, 2023 Category: Research Source Type: clinical trials